☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
NIAID
Eli Lilly Pauses Enrollment in ACTIV-3 Clinical Trial Due to Safety Concerns
October 15, 2020
Eli Lilly in Collaboration with NIAID Initiate P-III Study of LY-CoV555 to Prevent COVID-19
August 4, 2020
PharmaShots Weekly Snapshots (July 06 - 10, 2020)
July 13, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
